Catalyst
Slingshot members are tracking this event:
Kadmon Plans Five Phase 2 Trials for KD025 in Sept. 2016 (SLE,Psoriatic arthritis, cGVHD, IPF, Moderate to Severe Psoriasis)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KDMN |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 03, 2016
Occurred Source:
http://investors.kadmon.com/recent-press-releases/2016/06-03-2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sle, Psoriatic Arthritis, Cgvhd, Ipf, Moderate
